4. Gene Therapy of Duchenne Muscular Dystrophy
- 1 January 1997
- book chapter
- Published by Elsevier in Advances in Genetics
- Vol. 35, 117-153
- https://doi.org/10.1016/s0065-2660(08)60449-6
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Deletion analysis of the dystrophin‐actin binding domainFEBS Letters, 1994
- Direct gene transfer into mouse diaphragmFEBS Letters, 1993
- Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscleFEBS Letters, 1993
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992
- Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitroFEBS Letters, 1992
- Structural predictions for the central domain of dystrophinFEBS Letters, 1990
- Mosaic Expression of Dystrophin in Symptomatic Carriers of Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Functional regeneration in the hindlimb skeletal muscle of the mdx mouseJournal of Muscle Research and Cell Motility, 1988
- Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular DystrophyNew England Journal of Medicine, 1988